Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation

In this paper by Taylor et al (20 January, pp 321-6) the name of the drug used in antiplatelet treatment should have been indobufen, not indoprofen. Indoprofen was withdrawn from use worldwide after reports of carcinogenicity in animal studies.